maybe just stick to the trivial stuff lev. I realise comprehension mightn't be your strong suit. one of your first discussion of actual facts and you are a mile off !!!!!
the quarterlies under Ewen's leadership only give developments till the end of the quarter. so planning approval is most likely sorted.
"AnteoTech continues to progress the development and installation of the first stage AnteoX plant in Brisbane, with plans well developed and progressing to planning approval submission. Long lead time items have been purchased in anticipation of this approval and development remains on track for release of first commercial product early in 2024."
I put it bold to make it easier for you, "first commercial product early in 2024" !!!!!
- Forums
- ASX - By Stock
- ADO
- Ann: Application for quotation of securities - ADO
Ann: Application for quotation of securities - ADO, page-31
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.005(18.5%) |
Mkt cap ! $54.77M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $123.1K | 5.801M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1590 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 625000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 91590 | 0.022 |
13 | 2804316 | 0.021 |
21 | 3408245 | 0.020 |
8 | 3328823 | 0.019 |
14 | 3352391 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 625000 | 3 |
0.024 | 200000 | 1 |
0.025 | 40000 | 1 |
0.026 | 76000 | 2 |
0.027 | 486666 | 2 |
Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online